医学
甲状腺间变性癌
甲状腺癌
癌症
内科学
肿瘤科
癌症研究
作者
Sarah Hamidi,Ramona Dadu,Mark Zafereo,Renata Ferrarotto,Jennifer Wang,Anastasios Maniakas,G. Brandon Gunn,Anna Lee,Michael T. Spiotto,Priyanka Iyer,Luana Guimarães de Sousa,Neal S. Akhave,Salmaan Ahmed,Kim O. Learned,Charles Lu,Stephen Y. Lai,Michelle D. Williams,S. Mohsen Hosseini,Naifa L. Busaidy,Maria E. Cabanillas
出处
期刊：JAMA Oncology
[American Medical Association]
日期：2024-07-11
卷期号：10 (9): 1264-1264
被引量：4
标识
DOI：10.1001/jamaoncol.2024.2133
摘要
BRAF/MEK inhibitors revolutionized the treatment of BRAF V600E-variant anaplastic thyroid carcinoma (BRAFv-ATC), offering improved outcomes for patients with this previously incurable disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI
爱静静
SuperBean
asd
Luminous
竹筏过海
shinysparrow
我是站长才怪
cocolu
礼礼
嗯哼
囧囧
模糊中正
pcr163
Marciu33
nenoaowu
清爽老九
深情的火龙果
David
刻苦的尔白
Lyncus
皖公网安备34019202002308
